Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis

被引:128
|
作者
Buscariollo, Daniela L. [1 ]
Park, Henry S. [2 ]
Roberts, Kenneth B. [2 ,3 ]
Yu, James B. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
关键词
atypical teratoid rhabdoid tumor; central nervous system; epidemiology; radiotherapy; children; CENTRAL-NERVOUS-SYSTEM; TERATOID/RHABDOID TUMOR; RADIATION-THERAPY; CHILDREN; CHILDHOOD; CHEMOTHERAPY; INFANCY; ATRT;
D O I
10.1002/cncr.27373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Atypical teratoid rhabdoid tumor (ATRT) is a rare central nervous system malignancy with a poor prognosis that affects mostly young children. Although radiotherapy (RT) historically has been delayed in patients aged <3 years, emerging evidence suggests a role for RT to achieve long-term survivorship. Clinical features and age-dependent trends of RT use were evaluated for patients with ATRT. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results database was used to identify 144 patients with ATRT from 1973 to 2008. The primary endpoint was median overall survival (OS). Clinical and treatment variables were assessed for an association with OS using Cox proportional hazards models. Landmark analysis was used to correct for immortal time bias of adjuvant RT. RESULTS: The median age at diagnosis was 1 year (range, 0-67 years). Gross total resection of the primary tumor was achieved in 39% of patients, and 33% of patients received RT. From 1992 to 2008, RT use increased 2.4-fold in patients aged =3 years. The median OS for was 10 months. In multivariate analyses, metastatic disease (hazard ratio, 2.83; 95% confidence interval, 1.53-5.23; P = .001) and RT (hazard ratio, 0.10; 95% confidence interval, 0.01-0.73; P = .02) were identified as independent predictors of survival. Landmark analysis confirmed a robust association between RT use and survival, which was attenuated in patients ages 4 to 17 years compared with younger patients. CONCLUSIONS: The current results indicated that RT may offer a significant survival benefit for patients with ATRT and that patients aged =3 years may derive more benefit from initial RT compared with older children. The authors concluded that prospective clinical trials are needed to examine the role of RT in the initial management of ATRT in patients aged <3 years. Cancer 2012. (c) 2011 American Cancer Society.
引用
收藏
页码:4212 / 4219
页数:8
相关论文
共 50 条
  • [31] Myxopapillary Ependymoma: A Surveillance, Epidemiology, and End Results Analysis of Epidemiology and Outcomes
    Choi, G.
    Bates, J. E.
    Milano, M. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E76 - E76
  • [32] Early radiotherapy and high-dose chemotherapy improve survival of atypical teratoid rhabdoid tumors
    Yang, W. C.
    Hu, Y.
    Chen, Y.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S654 - S654
  • [33] Radiotherapy After Gross Total Resection of Skull Base Chordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes
    Gendreau, Julian
    Jimenez, Adrian
    Lozinsky, Shannon
    Zenonos, Georgios
    Gardner, Paul
    Raza, Shaan
    Dea, Nicolas
    Gokaslan, Ziya
    Choby, Garret
    Van Gompel, Jamie
    Redmond, Kristin
    Gallia, Gary
    Bettegowda, Chetan
    Rowan, Nicholas
    Kuo, Cathleen C.
    Mukherjee, Debraj
    WORLD NEUROSURGERY, 2023, 172 : E68 - E76
  • [34] Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR)
    Andrew Roehrig
    Daniel J. Indelicato
    Arnold C. Paulino
    Ralph Ermoian
    William Hartsell
    John Perentesis
    Christine Hill-Kayser
    Jae Y. Lee
    Nadia N. Laack
    Victor Mangona
    Iain MacEwan
    Bree R. Eaton
    Sara Gallotto
    Benjamin V. M. Bajaj
    Paul D. Aridgides
    Torunn I. Yock
    Journal of Neuro-Oncology, 2023, 162 : 353 - 362
  • [35] Disadvantage of survival outcomes in widowed patients with colorectal neuroendocrine neoplasm: an analysis of surveillance, epidemiology and end results database
    Li, Jing
    Wang, Ying
    Han, Fang
    Wang, Zhu
    Xu, Lichun
    Tong, Jiandong
    ONCOTARGET, 2016, 7 (50) : 83200 - 83207
  • [36] Impact of Radiotherapy on Survival of Patients With Limited Stage Mantle Cell Lymphoma - Analysis of Surveillance Epidemiology and End Results Database
    Murthy, Guru Subramanian Guru
    Venkitachalam, Raji
    Mehta, Paulette
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S142 - S143
  • [37] Survival benefit of radiotherapy to patients with small cell esophagus carcinoma - an analysis of Surveillance Epidemiology and End Results (SEER) data
    Song, Yaqi
    Wang, Wanwei
    Tao, Guangzhou
    Zhu, Weiguo
    Zhou, Xilei
    Pan, Peng
    ONCOTARGET, 2016, 7 (13) : 15474 - 15480
  • [38] A METRONOMIC ANTIANGIOGENIC COMBINATION THERAPY MAY PROLONG SURVIVAL FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR
    Slavc, Irene
    Peyrl, Andreas
    Chocholous, Monika
    Azizi, Amedeo
    Reisinger, Dominik
    Mayr, Lisa
    Gojo, Johannes
    Czech, Thomas
    NEURO-ONCOLOGY, 2018, 20 : 145 - 145
  • [39] Radiotherapy for Atypical Teratoid/=Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR)
    Roehrig, Andrew
    Indelicato, Daniel J.
    Paulino, Arnold C.
    Ermoian, Ralph
    Hartsell, William
    Perentesis, John
    Hill-Kayser, Christine
    Lee, Jae Y.
    Laack, Nadia N.
    Mangona, Victor
    MacEwan, Iain
    Eaton, Bree R.
    Gallotto, Sara
    Bajaj, Benjamin V. M.
    Aridgides, Paul D.
    Yock, Torunn I.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 162 (02) : 353 - 362
  • [40] CERVICAL ATYPICAL TERATOID RHABDOID TUMOR IN PEDIATRIC PATIENTS: A STUDY OF THE LAST DECADE
    Lima Fonseca Rodrigues, Amanda Cyntia
    Louro, Leticia Dos Santos
    Geddo Kostakis, Maria Eduarda
    Fialho, Milena Henriques
    Garcia Ruiz, Kananda Oliveira
    Saraiva Costa, Beatriz Patriota
    Vilela Gomes, Monique Benemerita
    NEURO-ONCOLOGY, 2022, 24 : 8 - 9